GlassScriptPhysician profile
Jennifer H Smith
NPI 1134237498
$8,105.73
in general payments reported to CMS, 2019-2025
51 companies · $866 in 2025
The $866 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,091 · 2020: $1,209 · 2021: $1,412 · 2022: $1,485 · 2023: $1,192 · 2024: $850 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,908.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,319.60 | 2019-2025 | Liletta, Orilissa, Lo Loestrin Fe |
| Amgen INC. | $800.85 | 2019-2025 | Evenity, Prolia, Prolia |
| Evofem Biosciences, INC. | $703.66 | 2020-2025 | Phexxi, Phexx, Solosec |
| Mayne Pharma Commercial LLC | $489.42 | 2021-2025 | |
| Allergan, INC. | $443.77 | 2019-2020 | |
| Coopersurgical, INC. | $343.71 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Novo Nordisk INC | $337.91 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $306.12 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $241.26 | 2019-2025 | Veozah, Myrbetriq |
| Organon LLC | $238.17 | 2021-2025 | Nexplanon |
| Therapeuticsmd, INC. | $237.07 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $170.32 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $161.22 | 2019-2025 | |
| Sage Therapeutics, LLC | $154.94 | 2020-2025 | Zurzuvae |
| Pfizer INC. | $151.41 | 2019-2025 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.